
Virucidal Testing in Healthcare – Which Standards Must Disinfectants Meet?
Introduction – What Does "Virucidal" Really Mean?
To be recognized as virucidal in a healthcare setting, a disinfectant must prove its effectiveness against highly resistant viruses in accordance with standards like EN 14476, EN 16777, and EN 17111.
EN 14476 – Suspension Test (Phase 2 / Step 1)
This is the fundamental lab test to evaluate antiviral effectiveness in suspension:
Involves Poliovirus, Adenovirus, Norovirus, and Vaccinia virus (both enveloped and non-enveloped).
Requires a ≥4 log reduction (10,000-fold drop in infectious titer) under "clean" or "dirty" conditions.
This is a mandatory requirement for products used on hands, surfaces, and tools in medical areas.
Phase 2 / Step 2 – Carrier-Based Testing
EN 16777 – Surface disinfection without mechanical action:
• Test viruses: Adeno, Noro, Polio, and Vaccinia.EN 17111 – Instrument disinfection:
• Test viruses: Adeno, Noro, optionally Parvovirus (at +40 °C), and Vaccinia.
What Does This Mean in Practice?
| Standard | Application | Test Viruses |
|---|---|---|
| EN 14476 | Suspension, hands/surfaces | Polio, Adeno, Noro, Vaccinia |
| EN 16777 | Contaminated surfaces | Adeno, Noro, Polio, Vaccinia |
| EN 17111 | Medical instruments | Adeno, Noro, (Parvo at 40°C), Vaccinia |
Products showing ≥4-log reduction under these tests provide assurance of reliable virucidal action in real medical settings.
Why Is This So Important?
Non-enveloped viruses (Polio, Adeno, Noro) are much harder to inactivate – they serve as the gold standard for disinfectant testing.
Without standardized testing, we couldn’t compare products or ensure their effectiveness.
Meeting these norms protects both patients and staff, and upholds safety and quality expectations in clinical settings.